Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Glucagon is a recognised therapy for the disorder ... Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication. "We at Zealand Pharma are acutely aware of the significant ...

DPP-4 inhibitors improve your blood sugar without making it drop too low alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia) glucagon-like peptides ...

Most of this rise was associated with the expansion of the sales force for recently purchased BAQSIMI. Revenues rose nearly six percent on a year-over-year basis to $191.2 million, some $3 million ...

Early detection of diabetes is crucial to prevent long-term complications. Here are some essential tips on how to identify early symptoms of diabetes and begin treatment promptly. Recognizing the ...

Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate ...